Charlottesville, VA (9 September 2009): Biovista Inc. announced today that it will present at the CHI Drug Repositioning Summit in Boston, MA, Oct. 13-14, 2009. The presentation will highlight the efficiencies of repositioning as a development strategy, and introduce Biovista’s proprietary platform for repositioning and adverse event profiling. BVA-101, 201 and 601 will be presented as … Read More
Events
Biovista Inc. to present at upcoming Marcus Evans repositioning con
Charlottesville, VA (8 September 2009) : Biovista announced today that it will present at the Marcus Evans 2nd Annual Drug Repositioning and Pipeline Enhancement conference in Philadelphia, PA, Sept. 17-18, 2009. The presentation will cover the advantages of repositioning as a component of portfolio development and lifecycle management, with specific Biovista drug case studies in … Read More
Biovista sponsors the 2009 Notch Meeting
Athens, GR, September 2nd, 2009 — Biovista Inc. is pleased to announce its sponsoring of the international 2009 Notch Meeting to be held in Athens, Greece, from September 27th to October 1st, 2009. The Notch Meeting is a biennial event on general Notch research that aims to reflect the diversity of Notch research and bring together researchers … Read More
Biovista to talk about its repositioning platform at the SBS 15th Annual Conference
Biovista Inc. Charlottesville, VA USA: February 11th, 2009 Biovista’s announced today that its CEO will be presenting at the 15th annual SBS Conference and Exhibition to be held in Lille, France in April of this year. The 2009 SBS conference is organised in sessions themed around Drug-Discovery Strategy, Drug-Discovery Technology and Target Biology. In the … Read More
Biovista sponsors EACL-09 Conference
Biovista announced today its sponsoring of the 12th Conference of the European Chapter of the Association for Computational Linguistics (EACL-09) to be held in Athens, Greece, 30 March – 3 April 2009. The conference covers a broad spectrum of disciplines working towards enabling intelligent systems to interact with humans using natural language, and towards enhancing human-human … Read More